• Info
  • Insider Ownership

Insider Trading & Ownership of Michael Kauffman

Location
Newton, MA
Summary
The estimated net worth of Michael Kauffman is at least $1,416,845 dollars as of 08 Jan 2026. Michael Kauffman is the Director of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $1.32M. Michael Kauffman is the President of Development, Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $86.7K. Michael Kauffman is the Director of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $8.4K.
Signature
/s/ Daniel Calkins, Attorney in Fact
All Insider Reports
All Insider Reports

Notify me when Michael Kauffman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Michael Kauffman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. Director $1,321,748 28 Feb 2022
VSTM Verastem, Inc. President of Development, Director $86,660 -$85,500 -50% 06 Jan 2026
ACET Adicet Bio, Inc. Director $8,437 21 Aug 2024
FGEN FIBROGEN INC Director 04 Jun 2025
KZR Kezar Life Sciences, Inc. Director 18 Jun 2025

Insider Transactions Reported by Michael Kauffman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.